{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:18:18Z","timestamp":1778858298855,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cjca.2024.01.026","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T05:20:43Z","timestamp":1706419243000},"page":"876-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-5049","authenticated-orcid":false,"given":"Carlo","family":"Fumagalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Zocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ciabatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2024.01.026_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.01.026_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.026_bib3","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.amjcard.2017.02.040","article-title":"Occurrence and natural history of clinically silent episodes of atrial fibrillation in hypertrophic cardiomyopathy","volume":"119","author":"Rowin","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2023.04.008","article-title":"Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring","volume":"381","author":"Fumagalli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy","volume":"119","author":"van Velzen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCHEARTFAILURE.120.007230","article-title":"Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry","volume":"13","author":"Canepa","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2024.01.026_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2023.2808","article-title":"Cardiac remodeling in subclinical hypertrophic cardiomyopathy","volume":"8","author":"Vissing","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2024.01.026_bib9","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.026_bib10","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.026_bib11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.026_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/heartjnl-2016-309672","article-title":"Predictors of atrial fibrillation in hypertrophic cardiomyopathy","volume":"103","author":"Guttmann","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.01.026_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2018.09.004","article-title":"Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy","volume":"273","author":"Cavigli","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","article-title":"Atrial myopathy","volume":"4","author":"Shen","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2024.01.026_bib15","doi-asserted-by":"crossref","first-page":"euad194","DOI":"10.1093\/europace\/euad194","article-title":"Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results","volume":"25","author":"Starek","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2024.01.026_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2020.07.036","article-title":"Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy","volume":"318","author":"Ciabatti","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehy625","article-title":"The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy","volume":"40","author":"Wasserstrum","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2024.01.026_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009796","article-title":"Development and validation of a clinical predictive model for identifying hypertrophic cardiomyopathy patients at risk for atrial fibrillation: the HCM-AF score","volume":"14","author":"Carrick","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1751-7176.2009.00251.x","article-title":"The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience","volume":"12","author":"Aslam","year":"2010","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.cjca.2024.01.026_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41598-019-57230-z","article-title":"Retrospective analysis of clinical phenotype and prognosis of hypertrophic cardiomyopathy complicated with hypertension","volume":"10","author":"Luo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2024.01.026_bib22","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.cjca.2023.06.415","article-title":"Clinical significance of postoperative atrial fibrillation in hypertrophic cardiomyopathy patients undergoing septal myectomy","volume":"39","author":"Bataiosu","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.cjca.2023.09.029","article-title":"Should we be looking at the forest or the trees? postoperative atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"39","author":"Aguilar","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131575","article-title":"Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy","volume":"395","author":"Losi","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2004.02.010","article-title":"Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"17","author":"Tani","year":"2004","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2024.01.026_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2022.06.017","article-title":"Left atrioventricular coupling index in hypertrophic cardiomyopathy and risk of new-onset atrial fibrillation","volume":"363","author":"Meucci","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib28","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence BJ, clinical correlations, mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.01.026_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.acvd.2020.06.004","article-title":"Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy","volume":"114","author":"Essayagh","year":"2021","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2024.01.026_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ehjci\/jeaa174","article-title":"Assessment of left atrial electro-mechanical delay to predict atrial fibrillation in hypertrophic cardiomyopathy","volume":"22","author":"Tjahjadi","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacep.2018.10.016","article-title":"Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by cardiac magnetic resonance imaging","volume":"5","author":"Sivalokanathan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/CIRCIMAGING.109.865683","article-title":"Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation","volume":"3","author":"Kuppahally","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2021.07.030","article-title":"Clinical utility of cardiac magnetic resonance imaging to assess the left atrium before catheter ablation for atrial fibrillation\u2014a systematic review and meta-analysis","volume":"339","author":"Ghafouri","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjcard.2015.12.058","article-title":"Impact of genotype on the occurrence of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"117","author":"Bongini","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005191","article-title":"Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy","volume":"11","author":"Lee","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2024.01.026_bib37","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/qjmed\/hcu046","article-title":"Prognostic value of two polymorphisms in nonsarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"107","author":"Orenes-Pi\u00f1ero","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.cjca.2024.01.026_bib39","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2024.01.026_bib40","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/heartjnl-2016-309406","article-title":"Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"102","author":"Providencia","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.01.026_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.78.1.44","article-title":"Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration","volume":"78","author":"Cecchi","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.01.026_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jelectrocard.2021.06.001","article-title":"Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: evidence for an extensive fibrotic disease","volume":"69","author":"Efremidis","year":"2021","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib43","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2047487319828474","article-title":"Risk factors for atrial fibrillation in hypertrophic cardiomyopathy","volume":"28","author":"Philipson","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib44","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1536\/ihj.18-438","article-title":"Associations between multiple circulating biomarkers and the presence of atrial fibrillation in hypertrophic cardiomyopathy with or without left ventricular outflow tract obstruction","volume":"60","author":"Liu","year":"2019","journal-title":"Int Heart J"},{"issue":"9658","key":"10.1016\/j.cjca.2024.01.026_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2024.01.026_bib47","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jcmg.2020.05.011","article-title":"Atrial dysfunction assessed by cardiac magnetic resonance as an early marker of fabry cardiomyopathy","volume":"13","author":"Bernardini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13506129.2020.1798922","article-title":"Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation","volume":"28","author":"Cappelli","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.cjca.2024.01.026_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015352","article-title":"Left atrial function predicts atrial arrhythmia recurrence following ablation of long-standing persistent atrial fibrillation","volume":"16","author":"Khan","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12968-021-00793-6","article-title":"Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study","volume":"23","author":"Raman","year":"2021","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjca.2024.01.026_bib51","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s10554-021-02232-0","article-title":"The predictive value of left ventricular and left atrial mechanics for atrial fibrillation and heart failure in hypertrophic cardiomyopathy: a prospective cohort study","volume":"37","author":"Zegkos","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hlc.2022.10.002","article-title":"Left atrial myopathy is associated with exercise incapacity and ventilatory inefficiency in hypertrophic cardiomyopathy","volume":"32","author":"Zegkos","year":"2023","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2024.01.026_bib53","first-page":"446","article-title":"Normal left atrial strain and strain rate using cardiac magnetic resonance feature tracking in healthy volunteers","volume":"21","author":"Truong","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/RLI.0000000000000219","article-title":"Left atrial 4-dimensional flow magnetic resonance imaging","volume":"51","author":"Markl","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib55","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.echo.2009.05.003","article-title":"The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study","volume":"22","author":"Geske","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2024.01.026_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12968-017-0420-0","article-title":"Left atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"19","author":"Farhad","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjca.2024.01.026_bib57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCGENETICS.113.000486","article-title":"Novel \u03b1-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias","volume":"7","author":"Girolami","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2024.01.026_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2024.01.026_bib59","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 guidelines for the management of cardiomyopathies ESC","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2024.01.026_bib60","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.jacc.2016.04.026","article-title":"Stroke and bleeding risks in NOAC- and warfarin-treated patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"67","author":"Noseworthy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2017.08.010","article-title":"Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"248","author":"Dominguez","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib62","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chest.2018.11.009","article-title":"Effectiveness and safety of non\u2013vitamin K antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy","volume":"155","author":"Jung","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2024.01.026_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.009777","article-title":"Anatomical characteristics of the left atrium and left atrial appendage in relation to the risk of stroke in patients with versus without atrial fibrillation","volume":"14","author":"Smit","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib64","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/0002-9149(83)90317-X","article-title":"Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil","volume":"51","author":"Bonow","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib65","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/hrt.32.5.652","article-title":"Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis","volume":"32","author":"Glancy","year":"1970","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2024.01.026_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0735-1097(86)80484-3","article-title":"Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy","volume":"7","author":"Stafford","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.STR.15.2.282","article-title":"Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis","volume":"15","author":"Furlan","year":"1984","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2024.01.026_bib68","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.amjcard.2019.02.051","article-title":"Safety, side effects and relative efficacy of medications for rhythm control of atrial fibrillation in hypertrophic cardiomyopathy","volume":"123","author":"Miller","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib69","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.541","article-title":"Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives","volume":"18","author":"Ammirati","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2024.01.026_bib70","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/bph.14223","article-title":"Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in\u00a0vitro study in human myocardium","volume":"175","author":"Ferrantini","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjca.2024.01.026_bib71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00380-014-0534-3","article-title":"Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide","volume":"30","author":"Haruki","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cjca.2024.01.026_bib72","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/pace.13310","article-title":"Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: a case series and literature review","volume":"41","author":"Moore","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib73","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/europace\/euq434","article-title":"Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation","volume":"13","author":"McCready","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2024.01.026_bib75","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2006.12.087","article-title":"Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"99","author":"Gaita","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib76","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/CIRCEP.113.000339","article-title":"Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy","volume":"6","author":"Santangeli","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib77","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jce.13645","article-title":"Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy","volume":"29","author":"Chen","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib78","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/jce.14137","article-title":"Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy","volume":"30","author":"Wen","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib79","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/europace\/euab022","article-title":"Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a european observational multicentre study","volume":"23","author":"Creta","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2024.01.026_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jce.14880","article-title":"Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes","volume":"32","author":"Castagno","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101524","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"48","author":"Faraz","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib82","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.hroo.2023.01.002","article-title":"Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: a proportional meta-analysis and systematic review of single-arm studies","volume":"4","author":"Latif","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.cjca.2024.01.026_bib83","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2008.01192.x","article-title":"Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"19","author":"Bunch","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib84","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ejcts\/ezx017","article-title":"Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy","volume":"51","author":"Lapenna","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2024.01.026_bib85","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/icvts\/ivx152","article-title":"Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study","volume":"25","author":"Bogachev-Prokophiev","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjca.2024.01.026_bib86","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2004.09.036","article-title":"Alcohol septal ablation versus surgical septal myectomy","volume":"44","author":"Talreja","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib87","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.hrthm.2023.08.028","article-title":"Atrioventricular nodal ablation is an effective management strategy for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"20","author":"Butcher","year":"2023","journal-title":"Heart Rhythm"},{"issue":"10253","key":"10.1016\/j.cjca.2024.01.026_bib88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (explorer-hcm): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2024.01.026_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jacc.2022.10.020","article-title":"Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Maron","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib90","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib91","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.026_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014986","article-title":"Myosin inhibition and left ventricular diastolic function in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy: insights from the VALOR-HCM study","volume":"15","author":"Cremer","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib93","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jcmg.2023.06.008","article-title":"Early observations on effects of mavacamten on left atrial function in obstructive hypertrophic cardiomyopathy patients","volume":"16","author":"Wessly","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2024.01.026_bib94","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T13:48:44Z","timestamp":1715694524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X24000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0828282X24000746"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2024.01.026","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}